Astrazeneca Ab

Johan Kajanus

Karl Henrik Edman

Andrew Turner

Annika Björe

Michael Kossenjans

Philip Cornwall

Gavin O'Mahony

Christina Olsson

David Cladingboel

Gert Strandlund

Carl Anders Hogner

Peter Gustaf Bonn

Carl-Gustav Sigfridsson

Adam Herring

Ulrik Gran

Gareth Ensor

Fritiof Ponten

Robert Lundqvist

Karl Anders Hogner

Karl Edman

Peter Bonn

Disclosed are certain derivatives of benzoxazinone amides of formula (I), or pharmaceutically acceptable salts thereof, (Formula (I)) that act as mineralocorticoid (MR) receptor modulators that may reduce oxidative stress in endothelium and hence improve vascular function, to methods for their potential therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds. 

Benzoxazinone amides as mineralocorticoid receptor modulators

Disclosed are certain derivatives of benzoxazinone amides of formula (I), or pharmaceutically acceptable salts thereof, that act as mineralocorticoid (MR) receptor modulators that may reduce oxidative stress in endothelium and hence improve vascular function, to methods for their potential therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.

There is provided compounds of formula I, wherein R, R, R, Rto R, X, Y and Z have meanings given in the description, which compounds are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.

Oxabispidine compounds for the treatment of cardiac arrhythmias

There is provided compounds of formula (I), wherein R, R, R, R, Rto R, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias. 

Oxabispidine compounds and their use in the treatment of cardiac arrhythmias

Growing community of inventors

Molndal, Sweden

Johan Kajanus